Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study
Open Access
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (8) , 985-992
- https://doi.org/10.1023/a:1008392927656
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group StudyJournal of Clinical Oncology, 1999
- Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)European Journal Of Cancer, 1999
- Paclitaxel induces significant changes in epidoxorubicin distribution in miceAnnals of Oncology, 1996
- DocetaxelDrugs, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Clinical Pharmacokinetics of EpirubicinClinical Pharmacokinetics, 1994
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic methodJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- NL-FIT: A microcomputer program for non-linear fittingComputer Programs in Biomedicine, 1983
- Reporting results of cancer treatmentCancer, 1981